Nucelion Therapeutics, a subsidiary of Bharat Biotech, has started operations to support life science innovators with scalable and high-quality processes for advanced therapies targeting cancers, autoimmune, and rare genetic disorders. The company aims to integrate these therapies into India's healthcare ecosystem.
Nucelion Therapeutics Launches to Revolutionize Advanced Therapies